CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-02 | Reasons Bryan M. Director | Option exercise | +4,507 | 24,072 | ||
| 2023-06-02 | Reasons Bryan M. Director | Option exercise · Restricted Stock Units | −4,507 | 0 | ||
| 2023-06-02 | SCHIFF ANDREW N Director | Option exercise | +4,507 | 4,507 | ||
| 2023-06-02 | SCHIFF ANDREW N Director | Option exercise · Restricted Stock Units | −4,507 | 0 | ||
| 2023-06-02 | Powell Andrew Kenneth William Director | Option exercise | +4,507 | 14,363 | ||
| 2023-06-02 | Powell Andrew Kenneth William Director | Option exercise · Restricted Stock Units | −4,507 | 0 | ||
| 2023-06-02 | Mehra Anand Director | Option exercise | +4,507 | 38,704 | ||
| 2023-06-02 | Mehra Anand Director | Option exercise · Restricted Stock Units | −4,507 | 0 | ||
| 2023-06-01 | Humphries William D. Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | Humphries William D. Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 | ||
| 2023-06-01 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | MILANO VINCENT Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 | ||
| 2023-06-01 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | GOWEN MAXINE Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 | ||
| 2023-06-01 | Molineaux Christopher P. Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | Molineaux Christopher P. Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 | ||
| 2023-06-01 | Reasons Bryan M. Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | Reasons Bryan M. Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 | ||
| 2023-06-01 | SCHIFF ANDREW N Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2023-06-01 | SCHIFF ANDREW N Director | Grant or award · Restricted Stock Units | +4,660 | 4,660 |
Page 19 of 34 · 680 trades